Firefly Neuroscience (AIFF) Capital Expenditures Growth (3y) (2013 - 2025)
Powered by 
Analysis
Firefly Neuroscience (AIFF) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 12.62% |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | -38.42% |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -46.07% |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 3.40% |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | -20.78% |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | - |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 28.92% |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -57.60% |
| Sep 30, 2025 | -24.90% |
| Jun 30, 2025 | -14.59% |
| Mar 31, 2025 | -15.91% |
| Sep 30, 2024 | 26.55% |
| Jun 30, 2024 | 53.08% |
| Dec 31, 2022 | 563.15% |
| Sep 30, 2022 | 429.45% |
| Jun 30, 2022 | 47.80% |
| Dec 31, 2021 | 100.86% |
| Sep 30, 2021 | 205.84% |
| Jun 30, 2021 | 392.89% |
| Mar 31, 2021 | 18.77% |
| Dec 31, 2020 | 91.59% |
| Dec 31, 2019 | -17.39% |
| Sep 30, 2019 | -9.96% |
| Jun 30, 2019 | 32.76% |
| Dec 31, 2018 | -39.08% |
| Sep 30, 2018 | -9.70% |
| Jun 30, 2018 | -71.95% |